NeutriSci International Inc (NU) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.006x

Based on the latest financial reports, NeutriSci International Inc (NU) has a cash flow conversion efficiency ratio of 0.006x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-5.90K ≈ $-4.27K USD) by net assets (CA$-914.77K ≈ $-661.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NeutriSci International Inc (NU) market capitalisation for the company's overall valuation and market capitalisation.

NeutriSci International Inc - Cash Flow Conversion Efficiency Trend (2001–2022)

This chart illustrates how NeutriSci International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NeutriSci International Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NeutriSci International Inc ranked by their cash flow conversion efficiency. Explore NeutriSci International Inc cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Meridian Bhd
KLSE:5040
-0.045x
Logistics Development Group PLC
LSE:LDG
-0.005x
Spectra Systems Corp
LSE:SPSY
0.210x
Tongyang Inc
KO:001527
0.020x
Migo Opportunities Trust PLC
LSE:MIGO
-0.009x
Braemar Plc
LSE:BMS
0.012x
Nexera Technologies Ltd.
NASDAQ:NEXR
-0.756x
Arcadia Biosciences Inc
NASDAQ:RKDA
-0.208x

Annual Cash Flow Conversion Efficiency for NeutriSci International Inc (2001–2022)

The table below shows the annual cash flow conversion efficiency of NeutriSci International Inc from 2001 to 2022. View NU live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2022-12-31 CA$-616.97K
≈ $-446.31K
CA$-166.09K
≈ $-120.15K
0.269x -98.77%
2021-12-31 CA$-47.60K
≈ $-34.43K
CA$-1.04 Million
≈ $-752.92K
21.866x +29.71%
2020-12-31 CA$-90.24K
≈ $-65.28K
CA$-1.52 Million
≈ $-1.10 Million
16.857x +112.24%
2019-12-31 CA$-156.24K
≈ $-113.02K
CA$-1.24 Million
≈ $-897.66K
7.943x +207.09%
2018-12-31 CA$275.79K
≈ $199.50K
CA$-2.05 Million
≈ $-1.48 Million
-7.417x +35.68%
2017-12-31 CA$131.39K
≈ $95.04K
CA$-1.51 Million
≈ $-1.10 Million
-11.530x -239.39%
2016-12-31 CA$664.22K
≈ $480.49K
CA$-2.26 Million
≈ $-1.63 Million
-3.397x -16.92%
2015-12-31 CA$726.98K
≈ $525.89K
CA$-2.11 Million
≈ $-1.53 Million
-2.906x -90.58%
2014-12-31 CA$928.71K
≈ $671.82K
CA$-1.42 Million
≈ $-1.02 Million
-1.525x -270.31%
2014-09-30 CA$2.66 Million
≈ $1.92 Million
CA$-1.10 Million
≈ $-792.22K
-0.412x -125.16%
2012-12-31 CA$-705.48K
≈ $-510.34K
CA$-1.15 Million
≈ $-835.27K
1.637x +1042.03%
2011-12-31 CA$-9.12 Million
≈ $-6.60 Million
CA$-1.31 Million
≈ $-945.19K
0.143x -24.73%
2010-12-31 CA$-6.64 Million
≈ $-4.80 Million
CA$-1.26 Million
≈ $-914.10K
0.190x -26.84%
2009-12-31 CA$-4.53 Million
≈ $-3.28 Million
CA$-1.18 Million
≈ $-853.79K
0.260x -58.59%
2008-12-31 CA$-2.79 Million
≈ $-2.02 Million
CA$-1.75 Million
≈ $-1.27 Million
0.629x -81.79%
2007-12-31 CA$-866.86K
≈ $-627.07K
CA$-2.99 Million
≈ $-2.16 Million
3.451x -89.81%
2006-12-31 CA$-59.05K
≈ $-42.71K
CA$-2.00 Million
≈ $-1.45 Million
33.870x +987.40%
2005-12-31 CA$-487.78K
≈ $-352.85K
CA$-1.52 Million
≈ $-1.10 Million
3.115x -54.65%
2004-12-31 CA$-250.32K
≈ $-181.08K
CA$-1.72 Million
≈ $-1.24 Million
6.868x +934.22%
2003-12-31 CA$1.06 Million
≈ $769.61K
CA$-875.87K
≈ $-633.59K
-0.823x +35.27%
2002-12-31 CA$137.29K
≈ $99.32K
CA$-174.62K
≈ $-126.32K
-1.272x -4043.61%
2001-12-31 CA$337.55K
≈ $244.18K
CA$-10.36K
≈ $-7.49K
-0.031x --

About NeutriSci International Inc

V:NU Canada Drug Manufacturers - Specialty & Generic
Market Cap
$1.83 Billion
CA$2.53 Billion CAD
Market Cap Rank
#30770 Global
#1597 in Canada
Share Price
CA$14.19
Change (1 day)
-5.53%
52-Week Range
CA$11.60 - CA$18.76
All Time High
CA$18.76
About

NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.